108 related articles for article (PubMed ID: 27177018)
1. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
Yang C; He H; Zhang T; Chen Y; Kong Z
Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
[TBL] [Abstract][Full Text] [Related]
2. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
[TBL] [Abstract][Full Text] [Related]
4. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
[TBL] [Abstract][Full Text] [Related]
5. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
6. ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway.
He H; Chang R; Zhang T; Yang C; Kong Z
Mol Med Rep; 2017 Aug; 16(2):1216-1222. PubMed ID: 28586028
[TBL] [Abstract][Full Text] [Related]
7. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells.
Chang R; He H; Mao G; Kong Z
Int J Radiat Biol; 2017 Apr; 93(4):386-393. PubMed ID: 27834104
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
[TBL] [Abstract][Full Text] [Related]
9. DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis.
Zhou J; Ning Z; Wang B; Yun EJ; Zhang T; Pong RC; Fazli L; Gleave M; Zeng J; Fan J; Wang X; Li L; Hsieh JT; He D; Wu K
Cell Death Dis; 2015 Oct; 6(10):e1955. PubMed ID: 26512963
[TBL] [Abstract][Full Text] [Related]
10. The role of DAB2IP in androgen receptor activation during prostate cancer progression.
Wu K; Liu J; Tseng SF; Gore C; Ning Z; Sharifi N; Fazli L; Gleave M; Kapur P; Xiao G; Sun X; Oz OK; Min W; Alexandrakis G; Yang CR; Hsieh CL; Wu HC; He D; Xie D; Hsieh JT
Oncogene; 2014 Apr; 33(15):1954-63. PubMed ID: 23604126
[TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of Hepatoma Up-Regulated Protein Inhibits γ-Irradiation-Induced Apoptosis of Prostate Cancer Cells.
Hassan M; El Khattouti A; Ejaeidi A; Ma T; Day WA; Espinoza I; Vijayakumar S; Gomez CR
J Cell Biochem; 2016 Jun; 117(6):1308-18. PubMed ID: 26505164
[TBL] [Abstract][Full Text] [Related]
12. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
Zhang X; Wang Q; Zhang R; Kong Z
Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
[TBL] [Abstract][Full Text] [Related]
13. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.
Chen H; Pong RC; Wang Z; Hsieh JT
Genomics; 2002 Apr; 79(4):573-81. PubMed ID: 11944990
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
[TBL] [Abstract][Full Text] [Related]
16. A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer.
Samadaian N; Salehipour P; Ayati M; Rakhshani N; Najafi A; Afsharpad M; Yazarlou F; Modarressi MH
Pathol Res Pract; 2018 Dec; 214(12):2018-2024. PubMed ID: 30301636
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy.
Jacobs C; Tumati V; Kapur P; Yan J; Xie XJ; Hannan R; Hsieh JT; Kim DW; Saha D
Cancer Med; 2015 Dec; 4(12):1844-52. PubMed ID: 26471467
[TBL] [Abstract][Full Text] [Related]
18. Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.
Chen H; Karam JA; Schultz R; Zhang Z; Duncan C; Hsieh JT
DNA Cell Biol; 2006 Apr; 25(4):232-45. PubMed ID: 16629596
[TBL] [Abstract][Full Text] [Related]
19. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
20. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
